Connected Hospitals Events, Seminars, & Publications 12. 06. 2023 ATTIKON, B Pre-educational Clinic, Director Professor Ms. Amanda Psirri.2nd Ambassador: Oncologist Ms. Panagiota Economopoulou. SOTIRIA, C Pathology Clinic, Director Professor Mr. Konstantinos Syrigos.Scientific Responsible – 2nd Ambassador: Oncologist Ms. Orianthi Fiste. General Hospital LARISSAS, Dental Department for Disabled, Director Mr. Grigorios Vlahakis, Scientific Responsible Ms. Paraskevi Siafaka.2nd Ambassador: Ms. Aikaterini Passa, Supervisor A. We sincerely thank and are grateful to the selected and prominent Hospitals of our Country, who chose to participate in the SymbIASIS program and to be associated with CureCancer - mycancer.gr.Our goal is to record and evaluate their demographic, social and economic needs as well as elements of their disease and treatment, which may affect the patients themselves and people with cancer experience, as well as their families. A particular innovation of CureCancer - mycancer.gr is the fact that the data is filled in by the patients themselves.
Medication-Related Osteonecrosis of the Jaw (MRONJ): From Theory to Practice – Advanced Training Webinar Events, Seminars, & Publications 28. 01. 2026 The Next Step in Managing Patients on Antiresorptive MedicationsOn January 16, 180 dentists attended our first webinar on MRONJ and risk assessment.The response was immediate:“The STEPS and their eval...[Read more]
The 3-Step Safety System for Medication-Related Osteonecrosis of the Jaw (MRONJ) Events, Seminars, & Publications 07. 04. 2026 How to Confidently Treat Patients Taking Antiresorptive MedicationsIn our first two webinars, more than 600 dentists discovered a system that changes the way they manage high-risk patients.Their react...[Read more]
Osteonecrosis of the Jaw (MRONJ): The 3-Step Safety System for Dentists Events, Seminars, & Publications 09. 06. 2026 How to Treat Patients Receiving Antiresorptive Medications with ConfidenceIn our previous webinars, hundreds of dentists discovered a system that has transformed the way they manage high-risk patients...[Read more]
